HvHMA1 rescues the decreased fresh weight of <i>Athma1</i> plants under high light conditions. by Maria Dalgaard Mikkelsen (121256)

CDDO-Me radioprotection decreases with progressive oncogenic manipulations in HBECs and in a matched NSCLC line. by Mariam El-Ashmawy (678638)

“…Immortalized HBECs with (A) lenti-<i>KRas</i>^V12, (B) lenti-<i>KRas</i>^V12 and sh<i>p53</i> knockdown, and (C) lenti-<i>KRas</i>^V12, sh<i>p53</i>, and <i>myc</i> overexpression. …”

MYCN overexpression leads to decreased <i>id2a</i> expression in early SCG. by Rodrigo Ibarra-García-Padilla (19697623)

XRP44X decreases tumour burden in a prostate cancer bone metastasis model. by Kostyantyn Semenchenko (112316)

Inhibition of Hsp90 abolished VEGF-mediated eNOS phosphorylation and decreased NO production and cell viability in BAECs. by Yuanzhuo Chen (802891)

Lovastatin improves microvascular function and decreases leukocyte rolling and adhesion during PbA infection. by Patricia A. Reis (109310)

Screening for gHgLgO interaction partners reveals decreased binding of the gO249 mutant to cell surfaces. by Lena Thiessen (17605194)

PE activity and a decreasing degree of pectin methyl-esterification were specific to pericarp tissues. by Hiromi Hyodo (484509)

“…One unit means a decrease in OD₆₂₀ per second. …”

Mutations in inverted DNA repeats in P_<i>ganS</i> decrease GanR binding. by Cameron Habib (4112590)

Introduction of the F region decreases the amount of extracellular PSMs and increases the amount of extracellular FnbA. by Chikara Kaito (230958)

Chronic DCF treatment decreases ATP content (a) and the energy charge (b) of striatal slices by Elisaveta Milusheva (45672)

DOX decreases body mass gain over time in a sub-chronic toxicity model. by Gonçalo C. Pereira (156673)

Pre-treatment of striatal slices by DCF decreases HDA uptake (a) and dopamine content (b) by Elisaveta Milusheva (45672)

AR1’s occurrence gives rise to a decreased preference of ABP for AR2 and 3. by Li-Dong Huang (5659273)

HAstV-8 (D471S, N512D) spike has decreased or no binding to FcRn compared to wild-type HAstV-8 spike. by Catalina Aguilera-Flores (21743843)

Pharmacological treatments decrease actin polymerization. by Romain Ferru-Clément (701878)

Triclabendazole decreases intracellular cAMP. by Yong Joo Lee (357685)

TIG3 decreases cell survival. by Tiffany M. Scharadin (345930)

“…<b>A</b> TIG3 expression decreases cell number. Values are mean ± SEM, n = 3. …”

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

Sphingomyelinase activity decreases in Alzheimer’s disease. by Alfred N. Fonteh (486638)